The origins of nerves containing calcitonin gene-related peptide (CGRP), neuropeptide Y (NPY), and substance P were investigated in the rat stomach, pancreas, and colon, using immunocytochemistry combined with retrograde tracing and surgical and chemical denervation procedures.
Compared with nerves containing vasoactive intestinal polypeptide (VIP) and galanin, which have primarily local origins in mammalian gut, CGRP-, NPY-, and substance P-immunoreactive nerves revealed dual extrinsic and intrinsic origins. lmmunocytochemistry combined with retrograde tracing showed that the extrinsic CGRP-and substance P-immunoreactive nerves in the stomach and pancreas originate from bilateral dorsal root ganglia mainly at levels T8-Tl l, while those of the colon are derived from bilateral ganglia at Sl and, to a lesser extent, Ll and L8. Chemical denervations showed that neurons in these ganglia form a sensory input to the gut, and that those containing CGRP form the largest proportion.
The results of combined retrograde tracing and immunocytochemistry indicated that extrinsic NPYimmunoreactive nerves originate from postganglionic sympathetic neurons lying in the coeliac and inferior mesenteric ganglia.
These nerves were located mainly around blood vessels in gut and pancreas, showed sensitivity to 8-hydroxydopamine, and thus are likely to be noradrenergic. The present study provides a detailed mapping of the origins of some of the major peptide-containing nerves of the rat gastroenteropancreatic tract, thus providing further information on the anatomy of the enteric innervation.
The existence of a widespread system of peptide-containing nerves is now well established for the gut and pancreas of mammals. Since the first description of substance P in enteric neurons (Nilsson et al., 1975; Pearse and Polak, 1975) more than 10 neuropeptides have been localized to gut nerves (Polak and Bloom, 1979; Furness and Costa, 1980; Schultzberg et al., 1980; Sundler et al., 1980; Bishop et al., 1982) and at least 8 neuropeptides have been found in the pancreatic innervation (Sundler et al., 1978; Larsson, 1979; Bishop et al., 1980; Prinz et al., 1983; Ghatei et al., 1984; Carlei et al., 1985) .
Two of the latest neuropeptides to be discovered are calcitonin gene-related peptide (CGRP) and neuropeptide Y (NPY). CGRP is a novel 37 amino acid peptide produced by alternative calcitonin gene expression (Amara et al., 1982; Rosenfeld et al., 1983) . CGRP has been found in autonomic and motor nerves, as well as in sensory nerves, where it frequently coexists with substance P (Gibson et al., 1984; Wiesenfeld-Hallin et al., 1984; Clague et al., 1985; Fischer et al., 1985; Gibbins et al., 1985; Lee et al., 1985a, b; Lundberg et al., 1985; Rodrigo et al., 1985; Takami et al., 1985; Terenghi et al., 1985; Gulbenkian et al., 1986; Stemini et al., 1986) . In the gastrointestinal tract and pancreas, CGRP-immunoreactive nerves have been found to have a wide distribution (Clague et al., 1985; Mulderry et al., 1985; Stemini and Brecha, 1986) . Preliminary findings have indicated that CGRP-immunoreactive somata can be visualized in the intestine but not in the stomach of colchicine-treated rats, suggesting that the nature of the CGRP innervation differs along the rat gut (Clague et al., 1985) . However, no systematic study has been made of the exact origins of these nerves.
Neuropeptide Y is a 36 amino acid residue peptide which has been localized by immunocytochemistry to the central nervous system and to nerves in several peripheral tissues, including the gut and pancreas (Lundberg et al., 1982 (Lundberg et al., , 1984a Fumess et al., 1983; Sundler et al., 1983; Ekblad et al., 1984a, b; Ferri et al., 1984; Carlei et al., 1985; Lee et al., 1985~) . It has been suggested that enteric NPY-immunoreactive nerves have a dual extrinsic and intrinsic origin Ferri et al., 1984; Polak and Bloom, 1984; Lee et al., 1985~) . It has also been reported that NPY immunoreactivity is frequently associated with sympathetic noradrenergic nerves (Lundberg et al., 1982 Hokfelt et al., 1983; Ekblad et al., 1984~; Ferri et al., 1984; Polak and Bloom, 1984; Lee et al., 1985~; Allen and Bloom, 1986) .
In the present study, the distributions and origins of CGRP-, NPY-, and substance P-immunoreactive nerves were determined in the stomach, pancreas, and colon of the rat and compared with those of 2 other major gut neuropeptides, vasoactive intestinal polypeptide (VIP) and galanin, which have primarily local origins.
Materials and Methods Animals Adult rats (Wistar; 150-250 gm) of both sexes were used in all experiments. Animals undergoing surgery were anesthetized with Diazepam (Roche Products; 10 mg/kg, i.p.) and fenthamylcitrate/fluanison (Hypnorm; Janssen Pharmaceuticals; 5 mg/kg, i.m.).
Colchicine injection
Colchicine was used to block granule transport in axons in order to increase the peptide content in the neuronal cell body. Colchicine (5 mg/kg; Sigma, UK) dissolved in saline was injected intraperitoneally (n = 5). The rats were killed 48 hr later with an overdose of sodium pentobarbitone (Euthatal; May and Baker). The stomach, pancreas, and colon were dissected out and processed for immunohistochemistry.
Capsaicin treatment
In order to destroy primary sensory afferents, capsaicin was applied. Rats (n = 10) were treated with capsaicin (8-methyl-N-vanillyl S-nonenamide; Fluka AG) emulsified in vehicle (10 mg/ml) containing 10% (vol/vol) ethanol, 10% (vol/vol) Tween 80, and 80% (vol/vol) isotonic saline. Neonatal rats received 50 mg/kg of capsaicin intraperitoneally on davs 2 and 3 of nostnatal life under light ether anesthesia. Control animals (n = 10) were injected with vehicle alone. The stomach, pancreas, and colon were collected from rats when adult (2-3 months old).
Surgical denervation Stomach and pancreas. Upper abdominal sympathectomy was performed in 5 rats. The procedure was essentially that of Holmes (1953) . The coeliac ganglion and plexus and the superior mesenteric ganglion were carefully stripped away without undue hemorrhage. The presence of ganglia and nerve plexus was verified on microscopic sections.
Bilateral subdiaphragmatic vagotomy (Shay et al., 1949) was carried out in a separate group of rats (n = 5).
All the animals were allowed to recover for 8 d postoperatively, after which time the stomach and pancreas were collected for immunocytochemistry.
Distal colon. Inferior mesenteric ganglionectomy and bilateral section of the pelvic nerve were performed in 5 rats. The inferior mesenteric ganglia and nerves around the lower part of the abdominal aorta and the inferior mesenteric artery were removed and the pelvic nerves sectioned proximal to the pelvic ganglia.
6-Hydroxydopamine treatment A separate group of rats (n = 5) was injected intraperitoneally with a freshly prepared solution of 6-hydroxydopamine hydrobromide (6-OHDA; Sigma) in saline with 0.1% ascorbic acid (100 mg/kg body weight) at 1, 7, and 8 d, and control animals (n = 5) were injected with saline alone at the same time. On day 9, animals were killed and the stomach, pancreas, and colon were removed for immunocytochemistry.
Combined immunocytochemistry
and retrograde tracing Retrograde tracing. The possible extrinsic origins of CGRP-, NPY-, and substance P-immunoreactive nerves in the rat stomach, pancreas, and distal colon were examined by combined immunocytochemistry and retrograde tracing, using the fluorescent dye True blue [truns-1,2-bis(5-amidino-2-bensofluranyl)
ethylene 2HCl] (Sigma) (Sawchenko and Swanson, 1981; Sharkey et al., 1983) . In 3 groups of 4 rats each, the stomach, pancreas, or distal colon was exposed in fully anesthetized rats and a 5-10 rc.1 suspension of True blue in distilled water (5% wt/vol) was injected into the duodenal and splenic lobes of the pancreas and the anterior and posterior walls of the stomach and distal colon, respectively, at 8-l 2 loci with a Hamilton microsyringe. In order to prevent tracer leakage into the peritoneal cavity, leading to false-positive labeling, the organs to be investigated were gently lifted out of the abdominal cavity and placed on Parafilm during the course of the injection. After each injection, the needle was left in place for 1 min. Before replacement into the abdomen the organs were thoroughly swabbed and the injection sites inspected, furthermore, a barrier formed by a plastic wound spray (Nobecutane; Astra Pharmaceuticals, Watford, UK) was applied to the surfaces ofdye-injected organs (Fox and Powley, 1986) .
To ensure that the retrograde labeling was specific for each injected organ and did not reflect uptake of circulating dye from the bloodstream, 10 ~1 of True blue was injected into the portal vein of 2 control rats, as this vein drains most of the blood from the digestive organs.
Tissue processing and quantijicution. Seven days after injection, the rats were anesthetized and perfused with 150-200 ml of 0.1 M phosphate-buffered 0.0 15 M saline (PBS, pH 7.2), followed by 300-400 ml of ice-cold paraformaldehyde solution (4% wt/vol in PBS). The dorsal root ganglia (from T4 to S2), and nodose ganglia, pelvic ganglia, coeliac ganglia, inferior mesenteric ganglia, spinal cord, and brain stem were dissected out and placed in an additional solution of paraformaldehyde for 1 hr, then washed extensively with PBS containing 15% (wt/vol) sucrose at 4°C for at least 24 hr. Alternate lo-pm-thick cryostat sections were processed for immunofluorescence staining with antisera to CGRP, NPY, and substance P (Table 1) . Sections were examined with a fluorescent microscope (Olympus AH-2) equipped for epi-illumination with filters having excitation wavelengths of 340-380 nm (True blue) and 450-490 nm (fluorescein). Localization of CGRP, NPY, or substance P immunoreactivity in True blue-labeled cell bodies was verified by changing filter systems without altering the focal plane. All True blue-labeled cells from alternate sections of each dorsal root ganglion were counted. The number of labeled cells in each ganglion was expressed as a percentage of the total labeled cells. The proportion of True blue-labeled cells that contained CGRP, NPY, or substance P immunoreactivity was also recorded.
Immunocytochemistry Tissues other than those in the retrograde tracing experiments were fixed with either 0.4% (wt/vol) p-benzoquinone (K&h-Light) or 4% paraformaldehyde. Tissues were washed thoroughly in several changes of PBS containing sucrose (15% wt/vol) and sodium azide (0.0 1 O/o wt/ vol) for at least 24 hr prior to sectioning. Cryostat sections ( 1 b pm) were cut and mounted on poly-L-lysine-coated slides (Huang et al., 1983) . The method of immunostaining employed was either indirect immunofluorescence (Coons et al., 1955) or the peroxidase-antineroxidase technique (Stemberger et al., 1970) . Antisera were raised in rabbits; their characteristics are summarized in Table 1 .
Results
Normal distribution Neuronal elements with CGRP, NPY, substance P, VIP, and galanin immunoreactivity were observed throughout the wall of the rat stomach and colon, and were also found in the pancreas. Briefly, CGRP-immunoreactive fibers were observed in the mucosa, submucosa, and muscle layers of the stomach (Fig.  1) and colon (Fig. 2) where they showed a frequent association with blood vessels. No CGRP immunoreactivity could be detected in neuronal cell bodies of either ofthe 2 main ganglionated plexuses of the stomach, even after treatment with colchicine. However, this treatment did allow demonstration ofa few CGRP- (Fig. 2B) substance P nerves were more abundant. NPY immunoreactivand submucous plexuses of the colon. A similar distribution of ity could be seen in moderate numbers of ganglion cells of both both NPY- (Fig. 3) and substance P-immunoreactive fibers was plexuses in the stomach and colon. The number and intensity identified in these 2 organs, except for the muscle layers, where of immunostaining of these cells increased following colchicine Figure 2 . Distribution of CGRP immunoreactivity in nerves of the rat colon. A, CGRP-immunoreactive fibers showing close associa the surface and glandular epthelium of colonic mucosa. x 3 10. B, Ganglion cells of the myenteric plexus of colon taken from a rat tre, colchicine. CGRP immunoreactivity can be seen in the cells. The paucity of immunoreactive fibers in surrounding muscle is an effect of the treatment. x 600. C, CGRP-immunoreactive fibers in the mucosa (M) and submucosa (SM) of normal rat colon. The fibers show a close ar with the submucosal blood vessels. x 225. 0, An area similar to that shown in C, taken from a rat neonatahy treated with capsaicin. F be discerned in the mucosa (M) and muscularis mucosae but no nerves are present around blood vessels. x 225. Same fixation and immum techniques as in Figure 1 . tion with ated with chemical isociation %bers can lostaining Figure 3 . Distribution of NPY immunoreactivity in nerves of the rat stomach. A, Inner edge of the circular muscle and the submucosa of normal rat stomach containing numerous NPYimmunoreactive fibers. x225. B, An area similar to that shown in A taken from a rat treated with 6-OHDA. NPYimmunoreactive fibers are missing from around blood vessels, but those in the muscle remain unaffected. x225. C, Ganglion cells of the myenteric plexus of stomach taken from a rat treated with colchicine. NPY immunoreactivity can be seen in some of the cells. x500. Cryostat sections of benzoquinone solution-fixed tissue immunostained by (A. B) the technique of indirect immunofluorescence and (C') the peroxidase-antiperoxidase technique. administration (Fig. 3C) . Similar results were obtained for substance P. VIP and galanin immunoreactivities were widespread in nerves of all layers of both stomach and colon, and could be demonstrated frequently in ganglion cells, particularly of the submucous plexus, both with and without colchicine treatment.
In the pancreas, CGRP immunoreactivity was localized to nerve fibers that ran in the inter-and intralobular spaces. They were often found in or around islets and near blood vessels (Fig.  4) . As previously reported (Stemini and Brecha, 1986) , CGRP immunoreactivity was also found in single or clustered endocrine cells (Fig. 4A) . No immunoreactive ganglion cells could be visualized even after colchicine treatment. NPY-containing fibers showed a similar distribution in the exocrine parenchyma and around vascular structures, but were not seen in association with endocrine cells. No immrmoreactive ganglion cells could be detected even after colchicine treatment. Substance P, VIP, and galanin immunoreactivities all showed fairly similar widespread distributions in the pancreas, with VIP-immunoreactive fibers being most abundant in and most frequently associated with the islets. Ganglion cells immunoreactive for VIP were seen with or without colchicine administration, but substance P and galanin were found only rarely in cell bodies after colchicine.
Chemical and surgical denervations
The effects of chemical and surgical denervations on CGRP-, NPY-, substance P-, VIP-, and galinin-immunoreactive nerves in the rat stomach, pancreas, and colon are summarized in Tables 2-4 . Neonatal capsaicin administration. Following neonatal capsaicin administration, CGRP-immunoreactive fibers almost completely disappeared from the stomach (Fig. 1, A, B) and pancreas. In contrast, only a moderate depletion of CGRPimmunoreactive nerve fibers was seen in the colon, this being most evident around blood vessels (Fig. 2, C, D) . In the stomach and colon, capsaicin treatment resulted in a decrease in the number of substance P-immunoreactive fibers in the mucosa and submucosa and in a complete loss of perivascular nerves, whereas no changes in the number of nerves were noticed in the muscle layers. In the pancreas, the population of substance P-immunoreactive nerves was reduced substantially and the perivascular staining completely abolished. There were no apparent changes in NPY-, VIP-, and galanin-immunoreactive nerves after capsaicin treatment.
Surgical denervations. All ofthe surgical denervations, except vagotomy, had the effect of reducing both CGRP-and substance P-immunoreactive nerve fibers, as after capsaicin treatment. Bilateral subdiaphragmatic vagotomy caused no obvious alterations. There was a loss of NPY-immunoreactive fibers from around blood vessels of the stomach and pancreas of the upper abdominal sympathectomized rats and of the denervated colon. None of the surgical denervation procedures had any apparent influence on either VIP-or galanin-immunoreactive nerves.
6-OHDA treatment. After 6-OHDA treatment, NPY-im- munoreactive nerves in the stomach (Fig. 3, A, B) , pancreas, and colon disappeared from around blood vessels and were reduced in number in the myenteric plexus. No changes in CGRP, substance P, VIP, or galanin immunoreactivities were observed.
Immunocytochemistry combined with retrograde tracing
Retrograde tracing experiments showed that the location of True blue-labeled cells was dependent on the organs into which the dye was injected. Injection into stomach resulted in the labeling of cells in bilateral T5-Ll dorsal root ganglia, with most (about 80%) of the labeled cells lying in T&T1 1 (Fig. 5) . True bluelabeled cells were also seen bilaterally in the nodose ganglia, dorsal motor nucleus of the vagus (Fig. 6) , and celiac ganglia. Occasionally True blue-labeled cells were found in the nucleus ambiguus. Injection of the tracer into the pancreas led to a similar distribution of labeled cells (Fig. 5) , except that there were fewer labeled cells than after the injection of the dye into the stomach. After injection into the distal colon, retrogradely labeled cells were seen in dorsal root ganglia on both sides in 2 groups of ganglia, L6-S 1 and T 13-Ll . The cells were mostly in ganglia at Sl and, to a lesser extent, at Ll and L6 levels (Fig.  5 ). Labeled cells were also found in the inferior mesenteric ganglia and intermediolateral cell column of the lumbosacral spinal cord, but not in the nodose or pelvic ganglia. Labeled cells in the dorsal root ganglia appeared to be of small (< 20 Km) and medium (20-40 pm) size. Injection of True blue into the portal vein, a control for nonspecific uptake of dye by the circulation, did not produce the labeling pattern observed after injection of the stomach, pancreas, and colon. Instead, very weakly labeled cells were found in all dorsal root ganglia.
Combined immunocytochemistry with retrograde tracing demonstrated that the majority (about 95%) of True blue-labeled cells in dorsal root ganglia that were identified by injection of the tracer into the stomach, pancreas, or descending colon contained CGRP immunoreactivity (Fig. 7) . In contrast, only about 50% of labeled cells in dorsal root ganglia following injection into the stomach or descending colon, and about 20% after injection into the pancreas, contained substance P immunoreactivity (Fig. 8) .
In the nodose ganglia, only a few True blue-labeled cells contained CGRP immunoreactivity, but no True blue and substance P colocalization was seen. No CGRP-or substance P-immunoreactive cell bodies were stained in the dorsal motor nucleus of the vagus, celiac ganglia, inferior mesenteric ganglia, or intermediolateral cell columns of the lumbosacral spinal cord.
Nearly 50% of True blue-labeled cells in celiac ganglia (Fig.  9 ) and inferior mesenteric ganglia contained NPY immunoreactivity. No NPY-immunoreactive cell bodies were found in the dorsal root ganglia, nodose ganglia, or dorsal motor nucleus of the vagus.
Discussion
The results of this investigation, together with those of previous studies, show that the stomach, pancreas, and colon of the rat are rich in nerves containing CGRP (Clague et al., 1985; Mulderry et al., 1985; Sternini and Brecha, 1986) , NPY Ekblad et al., 1984b; Ferri et al., 1984; Carlei et al., 1985; Lee et al., 198%) substance P (Schultzberg et al., 1980; Sundler et al., 1980; Jodal and Lundgren, 1983; Minagawa et al., 1984) , VIP (Bryant et al., 1976; Larsson et al., 1976; Bishop et al., 1980; Schultzberg et al., 1980; Jodal and Lundgren, 1983; Bishop et al., 1984; Ekblad et al., 1984a; Yiangou et al., 1985) and galanin (Ekblad et al., 1985; Melander et al., 1985; Bishop et al., 1986) .
In the present study, the distributions and origins of each type of peptide-containing nerve were determined. VIP-and galaninimmunoreactive nerve fibers were found to arise mainly from intrinsic sources in the rat gut and pancreas, as has been reported previously (Larsson et al., 1976; Jessen et al., 1980; Sundler et al., 1980; Ekblad et al., 1985; Melander et al., 1985; Bishop et al., 1986) . VIP-and galanin-containing nerve cell bodies could be identified easily in both organs without the use of colchicine, and the finding that surgical denervations did not result in any changes in their population indicates that they have an almost entirely intrinsic origin.
Although local NPY-and substance P-immunoreactive neuronal cell bodies were observed after colchicine treatment in areas of gut and pancreas, surgical denervations led to the partial abolishment of nerve fibers containing the 2 peptides, particularly from around blood vessels, thereby supporting the contention that these nerve fibers have dual origins from extrinsic and intrinsic neurons (Furness et al., 1982; Sundler et al., 1983; Ferri et al., 1984; Minagawa et al., 1984; Polak and Bloom, 1984; Lee et al., 1985~) .
Compared to nerves containing the other 4 neuropeptides, which showed similar results along the length of the gut, the CGRP-immunoreactive nerves differed in their response to surgical and chemical manipulations. In the stomach and pancreas, no local CGRP-immunoreactive cell bodies were seen, even after colchicine treatment. Upper abdominal sympathectomy removed almost all CGRP-immunoreactive nerve fibers. Thus, the CGRP-immunoreactive nerve fibers of the rat stomach and pancreas are extrinsic, but those of the colon, like those containing substance P and NPY, have dual origins, as local cell bodies were found and surgical denervation caused only a partial loss of CGRP-containing fibers.
Using retrograde tracing combined with immunocytochemistry, it was possible to establish the exact origins of those peptide-containing fibers whose cell bodies lay outside the gut and pancreas. The 2 peptides, CGRP and substance P, have been found, by both light and electron microscopy, to coexist in certain neurons (Wiesenfeld-Hallin et al., 1984; Fischer et al., 1985; Gibbins et al., 1985; Gibson et al., 1985; Lee et al., 1985a, b; Lundberg et al., 1985; Terenghi et al., 1985; Gulbenkian et al., 1986; Stemini et al., 1986) and our results showed that, in the rat stomach and pancreas, these nerves have similar distributions and share the same extrinsic origins. The finding that the gastropancreatic substance P innervation of the rat arises from bilateral dorsal root ganglia has been reported previously (Sharkey et al., 1984) , but we were able to reveal, in addition, that nearly all of the retrogradely labeled cells in these ganglia contain CGRP immunoreactivity. The dorsal root ganglion origin of the CGRP-immunoreactive fibers and the finding that they were abolished by capsaicin treatment indicates that these nerves are visceral afferents forming a major component of the sensory innervation of the rat foregut. Those substance P-containing nerves that share their extrinsic origins and also respond to capsaicin administration appear to form a lesser proportion of the sensory innervation. In fact, it has been suggested previously that extrinsic sensory substance P nerves form only a minor population in the gut and are confined to a perivascular location (Holzer et al., 1980; Furness et al, 1982) . An extrinsic sensory nature would explain why the CGRP innervation of the stomach and pancreas is not altered by vagotomy or 6-OHDA treatment. The loss of virtually all CGRP-immunoreactive and some substance P-immunoreactive fibers after upper abdominal sympathectomy is a result of the fact that afferent fibers from the dorsal root ganglia accompany the sympathetic nerves reaching the stomach and pancreas.
In the stomach, CGRP-immunoreactive nerve fibers were associated frequently with blood vessels and smooth muscles. They may participate in the regulation of blood flow, gastric muscle tone (Brain et al., 1984; Feher et al., 1986; Maton et al., 1986 ) and gastric acid release (Hughes et al., 1984 ; Tache et al., 1984a, b; Kraenzlin et al., 1985) . Since nearly all CGRPimmunoreactive nerve fibers in the stomach originate from the dorsal root ganglia, these functions could be mediated by axonal reflexes. Peptides in visceral afferents are known to travel mainly towards the periphery (Lundberg et al., 1980) , and such a reflex mechanism has been proposed for substance P nerves (Lundberg et al., 1985) . CGRP-immunoreactive nerves of the exocrine and endocrine pancreas may influence the activity of both organ components. The peptide inhibits pancreatic exocrine secretion (Kohler et al., 1986) , probably via specific receptors that have been found on acinar cells (Zhou et al., 1985) and its administration leads to inhibition of insulin release (Greely et al., 1985) .
In the colon, too, CGRP-immunoreactive fibers have an extrinsic and presumably sensory nature, being derived from cells in the bilateral dorsal root ganglia-mainly at the Sl level but also at Ll and L6 -some of which also contained substance P. The sensory component of the CGRP innervation of the colon consisted mainly of those fibers surrounding blood vessels, which, like those containing substance P, disappeared after capsaicin treatment. Thus, the CGRP innervation of the rat gut is not uniform. This differential distribution of CGRP nerves in the upper and lower gut suggests that they subserve different functions. Those of the upper gut appear to be mainly visceral afferents relaying nociceptive stimuli, while the large bowel receives a dual extrinsic and intrinsic supply. In the colon, the intrinsic CGRP-immunoreactive nerves may act as intemeurons or as postganglionic parasympathetic neurons in control of motility (Feher et al., 1986; Maton et al., 1986) . They could, for example, be afferents or inhibitory effecters in the myenteric reflex arc.
NPY-immunoreactive nerves in the gut and pancreas were found to have extrinsic and intrinsic origins, as has been suggested previously Ferri et al., 1984; Polak and Bloom, 1984; Carlei et al., 1985; Lee et al., 1985~) . Treatment with 6-OHDA removed NPY-immunoreactive nerves from around blood vessels and reduced their number in the myenteric plexus. Upper abdominal sympathectomy and colon denervation had the same effect as 6-OHDA treatment, suggesting colocalization of extrinsic NPY with noradrenergic sympathetic nerves, as has been reported (Lundberg et al., 1982 HSL felt et al., 1983; Ekblad et al., 1984~; Feni et al., 1984; Polak and Bloom, 1984; Lee et al., 198%; Allen and Bloom, 1986) .
Retrograde tracing combined with immunocytochemistry provided further evidence that the extrinsic NPY nerves come from postganglionic sympathetic neurons. Recently, Lindh et al. (1986) , using a combination of retrograde axonal tracing and indirect immunofluorescence, reported the projection of the postganglionic sympathetic neurons to the guinea pig pylorus; the majority of these cells were also immunoreactive to tyrosine hydroxylase. However, not all noradrenergic nerves in the gut and pancreas contain NPY, as only about half of True bluelabeled postganglionic sympathetic neurons contained NPY immunoreactivity. The intrinsic NPY-immunoreactive nerves are probably nonadrenergic Ekblad et al., 1984~; Ferri et al., 1984) and, in fact, an NPY immunoreactivity has been found in intramural neurons of the small intestine, which are also immunoreactive for VIP and peptide histidine isoleutine (PHI) (Ekblad et al., 1984a; Ferri et al., 1984) . Therefore, NPY-immunoreactive nerve fibers in the gut and pancreas may have various subpopulations and play different roles in the regulation of gut (Emson and DeQuidt, 1984; Lundberg et al., 1984a; Hubel and Renquist, 1985; Allen and Bloom, 1986; Hellstrom, 1986) and pancreatic (Moltz and McDonald, 1985) functions.
A problem that can occur during retrograde tracing procedures is the diffusion of dye from the injected organ into the peritoneal cavity and surrounding vasculature. Uptake of this leakage by terminals in other abdominal viscera may cause inaccurate maps of ganglion labeling (Amy, 1980; Van der Krans and Hoogland, '1982) . Recently, new methods for preventing such leakage have evolved; they include the use of gel foam (Lindh et al., 1986) or plastic wound spray (Fox and Powley, 1986) , both of which act as diffusion barriers. In the present study, dye leakage was blocked by the careful isolation and washing of the injected organ and the application of plastic skin.
In conclusion, we have produced a detailed mapping of the origin of major types of peptide-containing nerves of the gut and pancreas of the rat, including the origins of 2 that have not been traced previously. Our results extend previous investigations on the nature of these nerves, providing further information on the anatomy of the enteric innervation.
